Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.21% slid 1.94% to $161.91 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.11% falling 1.02% to 3,744.52 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.85% falling 1.15% to 29,926.94. This was the stock's second consecutive day of losses. Johnson & Johnson closed $24.78 short of its 52-week high ($186.69), which the company achieved on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF -2.56% rose 4.49% to $335.62, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.54% fell 1.07% to $87.44, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +1.10% fell 2.33% to $43.09. Trading volume (5.9 M) remained 1.4 million below its 50-day average volume of 7.2 M.